GlobalData on MSN7d
FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS treatment
The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb ...
ALS News Today3d
Zydus cleared to begin US trial of oral therapy usnoflast for ALS
Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.
PharmaTimes4d
Zydus announces USFDA Orphan Drug Designation for Usnoflast in ALS treatment
Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The designation ...
Yahoo Finance7d
FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS treatment
"FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS treatment" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has ...